Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application

The future of anti-CD20 monoclonal antibodies: are we making progress?

(2011) W. Alduaij et al.   BLOOD

Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?

(2011) E. Jensen-Jarolim et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

(2011) S. M. Rudman et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing

(2011) S. Lohse et al.   JOURNAL OF IMMUNOLOGY

A Soluble Form of the High Affinity IgE Receptor, Fc-Epsilon-RI, Circulates in Human Serum

(2011) Eleonora Dehlink et al.   PLoS One

New Antibody Conjugates in Cancer Therapy

(2011) Serengulam V. Govindan et al.   TheScientificWorldJOURNAL

Research and development of next generation of antibody-based therapeutics

(2010) Jing Li et al.   ACTA PHARMACOLOGICA SINICA

Cytokine regulation of low-affinity IgE receptor (CD23) on monocytes from asthmatic subjects

(2010) A. VECCHIARELLI et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Farletuzumab in epithelial ovarian carcinoma

(2010) Whitney A Spannuth et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

In pursuit of new anti-angiogenic therapies for cancer treatment

(2010) Jun Cai   Frontiers in Bioscience-Landmark

Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management

(2010) Katharina C. Kaehler et al.   SEMINARS IN ONCOLOGY

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies

(2010) Paolo A. Ascierto et al.   SEMINARS IN ONCOLOGY

Engineered therapeutic antibodies with improved effector functions

(2009) Tsuguo Kubota et al.   CANCER SCIENCE

Utility of Serum HER2 Extracellular Domain Assessment in Clinical Decision Making: Pooled Analysis of Four Trials of Trastuzumab in Metastatic Breast Cancer

(2009) Siân Lennon et al.   JOURNAL OF CLINICAL ONCOLOGY

Immune infiltration in human tumors: a prognostic factor that should not be ignored

(2009) F Pagès et al.   ONCOGENE

AllergoOncology: the role of IgE-mediated allergy in cancer

(2008) E. Jensen-Jarolim et al.   ALLERGY

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells

(2008) Panagiotis Karagiannis et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Folate receptor alpha as a tumor target in epithelial ovarian cancer

(2008) Kimberly R. Kalli et al.   GYNECOLOGIC ONCOLOGY

Recombinant Human Monoclonal IgA Antibody Against CEA to Recruit Neutrophils to CEA-Expressing Cells

(2008) Jun Zhao et al.   ONCOLOGY RESEARCH